Prasugrel vs. Ticagrelor for Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

被引:0
|
作者
Muhammad Shahzeb Khan
Muhammad Mustafa Memon
Muhammad Shariq Usman
Saed Alnaimat
Safi U. Khan
Abdur Rahman Khan
Naser Yamani
Setri Fugar
Farouk Mookadam
Richard A. Krasuski
Rami Doukky
机构
[1] John H Stroger Jr. Hospital of Cook County,Department of Internal Medicine
[2] Dow University of Health Sciences,Department of Internal Medicine
[3] University of Iowa Hospitals and Clinics,Department of Internal Medicine
[4] West Virginia University,Division of Cardiology
[5] University of Louisville,Department of Cardiovascular Diseases
[6] Mayo Clinic,Department of Cardiovascular Medicine
[7] Duke University Health System,Division of Cardiology
[8] Cook County Health and Hospitals System,Division of Cardiology
[9] Rush University Medical Center,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:465 / 476
页数:11
相关论文
共 50 条
  • [32] BUDGET IMPACT ANALYSIS OF PRASUGREL FOR PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN SPAIN
    Crespo, C.
    Talegon Albarino, I
    Garcia Garcia, J.
    Kasztanovits, Gross M.
    Martin Conde, J. A.
    Rodriguez Barrious, J. M.
    Barrios, J. M.
    VALUE IN HEALTH, 2017, 20 (09) : A607 - A607
  • [33] Ticagrelor vs clopidogrel when coadministered with bivalirudin in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Li, Yang
    Li, Yi
    Qiu, Miaohan
    Xue, Yu
    Xu, Kai
    Han, Yaling
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (03)
  • [34] Impact of Prasugrel and Ticagrelor on Platelet Reactivity in Patients With Acute Coronary Syndrome: A Meta-Analysis
    Dai, Lulu
    Xu, Jiawei
    Jiang, Yuerong
    Chen, Keji
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [35] Ticagrelor Versus Prasugrel for the Treatment of Patients with Type 2 Diabetes Mellitus Following Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
    Hua Yang
    Bing Tang
    Chen Hong Xu
    Anis Ahmed
    Diabetes Therapy, 2019, 10 : 81 - 93
  • [36] Ticagrelor Versus Prasugrel for the Treatment of Patients with Type 2 Diabetes Mellitus Following Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
    Yang, Hua
    Tang, Bing
    Xu, Chen Hong
    Ahmed, Anis
    DIABETES THERAPY, 2019, 10 (01) : 81 - 93
  • [37] BALANCING EFFICACY AND SAFETY OF PRASUGREL VS. CLOPIDOGREL IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A POPULATION ANALYSIS OF NET CLINICAL BENEFIT
    Schmitt, C.
    McCollam, P. L.
    Creveling, T. L.
    Oberdiek, A.
    VALUE IN HEALTH, 2009, 12 (07) : A317 - A317
  • [38] Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Turgeon, Ricky D.
    Koshman, Sheri L.
    Youngson, Erik
    Har, Bryan
    Wilton, Stephen B.
    James, Matthew T.
    Graham, Michelle M.
    JAMA INTERNAL MEDICINE, 2020, 180 (03) : 420 - 428
  • [39] Head to head comparison of Prasugrel versus Ticagrelor in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized trials
    Bundhun, Pravesh Kumar
    Shi, Jia-Xin
    Huang, Feng
    BMC PHARMACOLOGY & TOXICOLOGY, 2017, 18
  • [40] Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes
    Koshy, Anoop N.
    Giustino, Gennaro
    Sartori, Samantha
    Hooda, Amit
    Feng, Yihan
    Snyder, Clayton
    Dasgupta, Shabitri
    Kumar, Kartik R.
    Krishnamoorthy-Melarcode, Parasuram
    Sweeny, Joseph
    Khera, Sahil
    Serrao, Gregory W.
    Sharma, Raman
    Dangas, George
    Kini, Annapoorna S.
    Mehran, Roxana
    Sharma, Samin K.
    EUROINTERVENTION, 2023, 18 (15) : 1244 - +